Is the UK government delaying approval for new cancer drugs?

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.649, 2012-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Open-Label Extension Studies: Do They Provide Meaningful Information on the Safety of New Drugs?

By Day Richard O.   Williams Kenneth M.  

Drug Safety, Vol. 30, Iss. 2, 2007-01 ,pp. : 93-105

Adis International

Access to resources Recommend Favorite

Willingness-to-pay a better measure to value drugs?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Awakenings and Awareness Recovery in Disorders of Consciousness: Is There a Role for Drugs?

By Pistoia Francesca   Mura Elisa  

CNS Drugs, Vol. 24, Iss. 8, 2010-08 ,pp. : 625-638

Adis International

Access to resources Recommend Favorite

Why do Americans pay more for drugs?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 601, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

MicroRNA: Potential Targets for the Development of Novel Drugs?

By Wu Wei  

Drugs in R&D, Vol. 10, Iss. 1, 2010-05 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite